MRK.XETRA Merck KGaA

Healthcare Pharmaceuticals XETRA Stock Exchange
505.79 EUR
Close of Nov 5, 2026
98.72 152.10
Market cap
EUR 65.4B
P/E
27.6x
P/B
2.17x
ROE
7.6%
Dividend yield
1.59%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MRK.XETRA undervalued?

Graham number
Price505.79
Graham value310.22
Premium63.0%

MRK.XETRA trades 63.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Merck KGaA fundamental analysis

No fundamental analysis for Merck KGaA yet.

Merck KGaA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Merck KGaA

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomo…

Full company profile